3-(benzo[d][1,3]dioxol-5-yl)-3-(5-oxo-5-(1,2,3,4-tetrahydroisoquinolin-7-ylamino)pentanamido)propanoic acid hydrochloride

ID: ALA1208980

Chembl Id: CHEMBL1208980

PubChem CID: 49862105

Max Phase: Preclinical

Molecular Formula: C24H28ClN3O6

Molecular Weight: 453.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cl.O=C(O)CC(NC(=O)CCCC(=O)Nc1ccc2c(c1)CNCC2)c1ccc2c(c1)OCO2

Standard InChI:  InChI=1S/C24H27N3O6.ClH/c28-22(26-18-6-4-15-8-9-25-13-17(15)10-18)2-1-3-23(29)27-19(12-24(30)31)16-5-7-20-21(11-16)33-14-32-20;/h4-7,10-11,19,25H,1-3,8-9,12-14H2,(H,26,28)(H,27,29)(H,30,31);1H

Standard InChI Key:  NCLJCLRPKWSZNI-UHFFFAOYSA-N

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-3/beta-3 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 453.50Molecular Weight (Monoisotopic): 453.1900AlogP: 2.50#Rotatable Bonds: 9
Polar Surface Area: 125.99Molecular Species: ZWITTERIONHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.46CX Basic pKa: 8.62CX LogP: -0.85CX LogD: -0.88
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -0.45

References

1. Krysko AA, Krysko OL, Kabanova TA, Andronati SA, Kabanov VM..  (2010)  Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.,  20  (15): [PMID:20598885] [10.1016/j.bmcl.2010.06.051]

Source